Corcept Therapeutics (CORT)CEO sold ~$2M

~$2M

Approx. value · 40K sh @ $50.10

2.88M

Holds after · shares reported

Traded

May 1, 2026

Filed

May 6, 2026

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

1. Mar 4, 2026InsiderOfficer sold ~$296K of CORT shares in the open market
2. Mar 17, 2026Insider · 1 personInsiders: 2 purchases (~$3.3M)
3. Mar 20, 2026InsiderOfficer sold ~$424K of CORT shares in the open market
4. Mar 25, 2026InsiderCEO sold ~$1.31M of CORT shares in the open market
5. Apr 7, 2026InsiderOfficer sold ~$819K of CORT shares in the open market
6. Apr 30, 2026Company filing · Form 8-K · Results, Reg FDReported its results, and shared information with investors
7. May 1, 2026 · this disclosureInsiderCEO sold ~$2M of CORT shares in the open market

What came next

1. May 5, 2026InsiderOfficer sold ~$1.04M of CORT shares in the open market
2. May 21, 2026Company filing · Form 8-K · Executive change, Shareholder voteChanged a top executive or board member, and held a shareholder vote“On May 21, 2026, Corcept Therapeutics Incorporated (the “Company”) held its 2026 Annual Meeting of Stockholders (the “Annual Meeting”).”
3. May 27, 2026Insider · 2 peopleInsiders: 3 sales (~$5.2M)
4. Jun 1, 2026Insider · 3 peopleInsiders: 4 sales (~$5.5M)
5. Jun 2, 2026InsiderOfficer sold ~$1.41M of CORT shares in the open market
6. Jun 15, 2026Insider · 1 personInsiders: 4 sales (~$3.2M)
7. Jun 16, 2026Insider · 1 personInsiders: 2 sales (~$832K)
8. Jun 17, 2026InsiderDirector sold ~$1.69M of CORT shares in the open market
9. Jul 1, 2026Insider · 1 personInsiders: 3 sales (~$2.2M)
10. Jul 7, 2026Insider · 1 personInsiders: 2 sales (~$1.9M)
11. Jul 15, 2026Insider · 2 peopleInsiders: 8 sales (~$4.4M)
12. Jul 29, 2026Company filing · Form 8-K · Results, Reg FDReported its results, and shared information with investors
13. Jul 30, 2026Insider · 1 personInsiders: 13 sales (~$9.2M)
14. Aug 3, 2026Insider · 2 peopleInsiders: 2 sales (~$2.5M)
15. Aug 4, 2026InsiderOfficer sold ~$419K of CORT shares in the open market
16. Aug 10, 2026Insider · 2 peopleInsiders: 3 sales (~$2.0M)
17. Aug 14, 2026Insider · 2 peopleInsiders: 4 sales (~$1.5M)
18. Aug 17, 2026InsiderOfficer sold ~$1.16M of CORT shares in the open market
19. Aug 18, 2026Insider · 1 personInsiders: 4 sales (~$12.3M)
20. Aug 25, 2026Insider · 1 personInsiders: 2 sales (~$3.9M)

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Corcept Therapeutics

For Corcept Therapeutics, OQRO holds 64 insider filings (SEC Form 4 or Form 144) and 5 fund holdings reports (13F) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its CORT page.

Other recent filings by Joseph K Belanoff, Chief Executive Officer

• SEC Form 4 at Corcept Therapeutics (CORT)Jun 3, 2026
• SEC Form 4 at Corcept Therapeutics (CORT)Mar 28, 2026
• SEC Form 4 at Corcept Therapeutics (CORT)Dec 4, 2025
• SEC Form 4 at Corcept Therapeutics (CORT)Nov 6, 2025
• SEC Form 4 at Corcept Therapeutics (CORT)Nov 6, 2025

The full history of Joseph K Belanoff, Chief Executive Officer is on the profile page.

How this filing works

• SEC Form 4
• Open-market purchase
• Rule 10b5-1 trading plans

Other disclosures at Corcept Therapeutics

• SEC Form 4Oct 6, 2026
• SEC Form 4Oct 6, 2026
• SEC Form 4Oct 6, 2026
• SEC Form 4Oct 6, 2026
• SEC Form 4Oct 6, 2026
• SEC Form 4Oct 6, 2026

Everything OQRO holds on this company is on its CORT page.